April 3, 2019
AgomAb Therapeutics Completes Euros 21m Series A Financing
EUR 21m Series A secured with international investor syndicate co-led by V-Bio Ventures (Belgium) and Advent France Biotechnology (France), and…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: AgomAb Therapeutics